Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
China Traditional Chinese Medicine (570 HK)
Watchlist
240
Analysis
Health Care
•
Hong Kong
China Traditional Chinese Medicine Co. Limited, through its subsidiaries, manufactures and sells medicine and pharmaceutical products in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Singapore Press Holdings
•
09 May 2021 07:38
Last Week in Event SPACE: Singapore Press, Tabcorp, Invesco Office, Justbon, IHH Healthcare, JD.com
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
330 Views
Share
bullish
•
Intouch Holdings
•
30 Apr 2021 08:00
(Mostly) Asia M&A: April 2021 Roundup
The average premium for the new deals announced (or first discussed) in April was ~13%, with a year-to-date average of ~30% (66 deals).
David Blennerhassett
Follow
375 Views
Share
bullish
•
Tencent
•
11 Apr 2021 07:13
Last Week in Event SPACE: Naspers/Tencent, Toshiba, Coca-Cola Amatil, Invesco J-REIT, Tabcorp
The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...
David Blennerhassett
Follow
396 Views
Share
bullish
•
Jardine Strategic Holdings
•
31 Mar 2021 11:29
(Mostly) Asia M&A: March 2021 Roundup
The average premium for the new deals announced (or first discussed) in March was ~31%, with a year-to-date average of ~31% (57 deals).
David Blennerhassett
Follow
285 Views
Share
bullish
•
Kerry Logistics Network
•
26 Feb 2021 10:50
(Mostly) Asia M&A: February 2021 Roundup
The average premium for the new deals announced in February was ~27.5%, with a year-to-date average of ~31%. This compares to the average premium...
David Blennerhassett
Follow
400 Views
Share
First
Previous
41
42
43
44
45
46
47
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x